Ionis Pharmaceuticals (IONS) Tax Provisions (2009 - 2026)

Ionis Pharmaceuticals' Tax Provisions history runs 17 years deep, the most recent figure standing at $218000.0 for Q1 2026.

• In Q1 2026, Tax Provisions rose 87.93% year-over-year to $218000.0; the TTM figure through Mar 2026 stood at $1.9 million (up 131.01% YoY), while the FY2025 annual figure was $1.8 million, up 128.94% from the prior year.
• Tax Provisions was $218000.0 for Q1 2026 at Ionis Pharmaceuticals, down from $1.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $11.4 million in Q1 2023 to a low of -$3.6 million in Q3 2024.
• Historically, Tax Provisions has averaged $2.4 million across 5 years, with a median of $300000.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions jumped 2585.48% in 2022, then slumped 154.55% in 2024.
• A 5-year view of Tax Provisions shows it stood at $8.1 million in 2022, then dropped by 20.17% to $6.5 million in 2023, then sank by 141.12% to -$2.7 million in 2024, then jumped by 155.34% to $1.5 million in 2025, then sank by 85.25% to $218000.0 in 2026.
• The last three Tax Provisions figures came in at $218000.0 (Q1 2026), $1.5 million (Q4 2025), and $213000.0 (Q3 2025), per Business Quant data.